Impact of Preoperative Cannabis Use on Clinical Outcomes of Spinal Fusion-Systematic Review and Meta-analysis.
Preoperative cannabis use spinal fusion outcomes show patients tend to consume more opioids during and after surgery. This use may also lead to longer hospital stays and increased readmission rates. Understanding these outcomes helps clinicians better…
Alleviates Community Chronic Pain and Inflammation Accelerate
✦ New CED Clinical Relevance #77 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. PainCBDResearchSafetyPolicyAnxietyMental Health Why This Matters Clinicians treating rheumatoid arthritis patients…
Guest columnist: Washington should ensure stable hemp market | State-Journal
✦ New CED Clinical Relevance #47 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyHempCBDIndustrySafetyResearchDosing Why This Matters Clinicians prescribing or recommending hemp-derived…
Cannabinoid-Based Therapies Linked to Reduced Agitation in Alzheimer’s Patients, Meta …
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchNeurologyCBDAgingMental HealthSafetyTHC Why This Matters Clinicians managing behavioral symptoms in…
Michigan universities can’t study dispensary pot on campus. MSU went mobile
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchSafetyIndustryNeurologyMental HealthAnxiety Why This Matters Restrictions on campus-based cannabis research…
DEA Judge Issues Procedural Order for Marijuana Rescheduling Hearing
The DEA marijuana rescheduling procedural order sets the framework for the upcoming hearing on moving cannabis to Schedule III. This order establishes evidentiary standards that will influence federal cannabis research and clinical use. Clinicians should…
PleoPharma Announces 1st Patient Dosed in Phase 3 Clinical Trial for Cannabis Use Disorder
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchMental HealthCBDSafetyDosingIndustryHemp Why This Matters Clinicians currently lack FDA-approved pharmacotherapy…
GLP-1 Weight Loss: Cardiovascular Evidence in Women, Seniors
GLP-1 breast cancer risk reduction is an emerging finding from a large observational study showing about 30% fewer breast cancer cases in women using GLP-1 receptor agonists. This potential protective effect adds to the cardiovascular and metabolic…
Understanding Semaglutide Pricing and Access Challenges
Semaglutide pricing and access remain significant barriers for uninsured patients seeking GLP-1 therapy. High out-of-pocket costs often lead to treatment discontinuation despite clinical benefits. Understanding affordability options is essential for…
GLP-1 Receptor Agonists: Clinical Evidence & Outcomes
GLP-1 receptor agonists clinical evidence and outcomes highlight benefits beyond weight loss, including appetite regulation and metabolic improvements. Patients report enhanced satiety and reduced cravings contributing to adherence. Understanding these…